|
業務類別
|
Biotechnology |
|
業務概覽
|
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects. |
| 公司地址
| 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210 |
| 電話號碼
| +1 617 807-4062 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.seaporttx.com |
| 員工數量
| 58 |
| Ms. Daphne Zohar |
President, Chief Executive Officer and Director |
美元 768.92K |
10/04/2026 |
| Ms. Lauren A. White |
Chief Financial Officer and Principal Accounting Officer |
-- |
27/04/2026 |
| Dr. Michael C Chen, PhD |
Chief Scientific Officer |
美元 414.00K |
10/04/2026 |
| Ms. Lana Gladstein, J.D. |
General Counsel |
-- |
10/04/2026 |
| Dr. Antony Loebel, PhD |
Chief Medical Officer and President, Clinical Development |
美元 465.75K |
10/04/2026 |
|
|
| Ms. Sandra E. Peterson |
Independent Director |
10/04/2026 |
| Dr. Steven M. Paul, M.D. |
Chairman of the Board |
10/04/2026 |
| Dr. James I. Healy, M.D.,PhD |
Independent Director |
10/04/2026 |
| Mr. Robert J. Hombach |
Independent Director |
10/04/2026 |
| Dr. Sharon Mates, PhD. |
Independent Director |
27/04/2026 |
| Ms. Daphne Zohar |
President, Chief Executive Officer and Director |
10/04/2026 |
| Dr. Eric Elenko, PhD |
Independent Director |
10/04/2026 |
| Mr. Robert Nelsen |
Independent Director |
27/04/2026 |
| Dr. Jason Pitts, PhD |
Independent Director |
10/04/2026 |
| Ms. Denice Torres, J.D. |
Independent Director |
10/04/2026 |
| Dr. David Wheadon, M.D. |
Independent Director |
10/04/2026 |
| Mr. Robert Lyne |
Independent Director |
27/04/2026 |
|
|
|
|
